I.A. OTMAKHOVA¹, V.V. KRASNOV¹, B.Ya. GADIROVA¹, Zh.E. ZUEVA¹, L.G. SHAROVA²

¹Volga Research Medical University of the MH of RF, Nizhny Novgorod

² «Aleksandriya» Clinic, Nizhny Novgorod

 Contact:

Otmakhova I.A. ― PhD (medicine), Associate Professor of the Department of Infectious Diseases

Address: 10/1 Minin and Pozharsky sqr., Nizhny Novgorod, Russian Federation, 603950, tel. +7-906-360-49-48, e-mail: inf.bol@pimunn.ru

 Objective ― to present a brief literature review and a clinical case of asymptomatic course of parvovirus B19 infection in a pregnant woman with intrauterine fetal damage.

Material and methods. Literary sources were studied, medical documents were analyzed (ambulatory observation cards and medical histories of in-patients).

Results. A brief literature review on parvovirus infection is presented. Peculiarities of the clinical course of parvovirus infection in adults are investigated. A clinical case of asymptomatic course of parvovirus infection in a pregnant woman with intrauterine fetal damage is presented (development of non-immune hydrops).

Conclusion. The main clinical manifestations of the disease in adults are not specific and this disease is difficult to diagnose. As transplacental transmission from mother to fetus with the development of non-immune fetal hydrops is possible, even under asymptomatic course, it is necessary to raise awareness among doctors about the possible consequences of this infection, and to examine pregnant women who contacted parvovirus B19 infection patients for the early etiological diagnosis of the pathological process.

Key words: parvovirus B19, rash, pregnancy, non-immune hydrops of the fetus.

(For citation: Otmakhova I.A., Krasnov V.V., Gadirova B.Ya., Zueva Zh.E., Sharova L.G. Parvovirus infection in adults: clinical manifestations and the importance of asymptomatic forms (clinical observation). Practical medicine. 2019. Vol. 17, №8, P. 121-124)

REFERENCES

1. Klinicheskie rekomendatsii [proekt] po diagnostike, lecheniyu i profilaktike vrozhdennoy infektsii, vyzvannoy parvovirusom B19V [], 2016. 18 p.
2. Elnifro E., Nisha A.K., Almabsoot M. et al. Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya. Infect Developing Countries, 2009, vol. 3, pp. 218-220.
3. Mirambo M., Maliki F., Majigo M. et al. The magnitude and correlates of Parvovirus B19 infection among pregnant women attending antenatal clinics in Mwanza, Tanzania. BMC Pregnancy and Childbirth, 2017, vol. 17, p. 76.
4. Nakamura Y., Ohsawa I., Goto Y. et al. The Impact of Human Parvovirus B19 Infection on Heart Failure and Anemia with Reference to Iron Metabolism Markers in an Adult Woman. Internal Medicine, 2018, vol. 57, pp. 403-407.
5. Crane J., Mundle W., Boucoiran I. Parvovirus B19 infection in pregnancy. Obstet. Gyneacol. Can, 2014, vol. 36 (12), pp. 1107-1116.
6. Rahbar N., Valizadeh S., Ghorbani R. et al. Prevalence of Parvovirus B19 specific antibody in pregnant women with spontaneous abortion. Actamedica Iranica, 2015, vol. 53 (3), pp. 168-172.
7. Zajkowska A., Garkowski A., Czupryna P. Seroprevalence of parvovirus b19 antibodies among young pregnant women or planning pregnancy, tested for toxoplasmosis. Przeglepidemiol, 2015, vol. 69, pp. 479-482.
8. Maple P., Hedman L., Dhanilall P. et al. Identification of past and recent Parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study. Clinical Microbiology, 2014, vol. 52, pp. 947-956.
9. Filippone C., Zhi N., Wong S. et al. VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology, 2010, 374 (2), pp. 444-452.
10. Shabani Z., Esghaei M., Keyvani H. et al. Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Islam, 2015, vol. 7 (29), p. 197.
11. Subtil D., Garabedian C., Chauvet A. Parvovirus B19 infection and pregnancy. Presse Med, 2015, vol. 44, pp. 647-653.
12. Cotmore S.F., Chiorini J.A. The family Parvoviridae. Archives of Virology, 2014, vol. 159, pp. 1239-1247.
13. Bonvicini F., Puccetti C., Salfi N.C. et al. Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis. Clin. Microbiol, 2011, no. 10, pp. 3514-3518.
14. Tesapirat L., Wanlapakorn N., Chieochansin T. et al. Parvovirus b19 infection presenting as acute hepatitis and transient anemia in a previously healthy child. Trop. Med. Public Health, 2015, no. 2, pp. 226-230.
15. Valencia P.G., Nakazawa Y.E., Rodríguez D.E. et al. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. Colomb Med. (Cali), 2017, no. 3, rr. 105-112.
16. Juhl D., Gorg S., Hennig H. Persistence of parvovirus B19 (B19V) DNA and humoral immune response in B19V – infected blood donors. Vox Sang, 2014, no. 3, pp. 226-232.
17. Bonjoch X., Obispo F., Alemany C. et al. Characterization of markers of the progression of human parvovirus B19 infection in virus DNA-positive plasma samples. Transfus. Med. Hemother, 2015, no. 4, rr. 233-238.
18. Nadimpalli S.S., Miller R.S., Kamath V.M. et al. Congenital parvovirus B19 infection: persistent viremia and red blood cell aplasia. Open Forum Infect, 2015, no. 2.
19. Nikishov O.N., Kuzin A.A., Antipova A.Yu., Lavrent’eva I.N. Parvovirus infection — a modern problem in epidemiology and clinical medicine. Epidemiologiya i vaktsinoprofilaktika, 2015, vol. 14 (4), pp. 29-35 (in Russ.).
20. Ryumin A.M., Sobolevskaya O.L., Sobchak D.M. Cytomegalovirus as a causative agent of intrauterine infection. Dal’nevostochnyy zhurnal infektsionnoy patologii, 2017, no. 33, pp. 89-94 (in Russ.).